Fortress Biotech Inc (FBIO) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Fortress Biotech Inc   (NASDAQ: FBIO)
 

Fortress Biotech Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Fortress Biotech Inc inventory turnover ratio, the Fortress Biotech Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.34 in the second quarter 2026, yet the ratio remained below the average, as FBIO's market remain challenging.Average inventory processing period, for the Fortress Biotech Inc in Jun 30 2026 quarter, has decreased to 156 days, compare to 178 days, in the Mar 31 2026 quarter.

Within Healthcare sector 166 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1445 in the first quarter 2026, to 1540.

FBIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Fortress Biotech Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FBIO Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -36.54 % -25.64 % -33.31 % 0.25 % 32.67 %
Y / Y Cost of Sales Growth 7.26 % 29.81 % 107.96 % 8.89 % -12.44 %
Inventory Turnover Ratio (TTM) 2.34 2.05 1.79 1.43 1.4
FBIO's Total Ranking # 1540 # 1445 # 1527 # 1470 # 1577
Average inventory processing period 156 178 204 254 261
Seq. Inventory Growth -12.23 % -3.45 % -18.56 % -8.05 % 2.85 %
Seq. Cost of Sales Growth -1.21 % 33.66 % -19.17 % 0.49 % 19.56 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 46
Healthcare Sector # 167
Overall Market # 1540

Inventory Turnover Ratio Statistics
High Average Low
56.04 10.89 1.4
(Jun 30 2018)   (Jun 30 2025)



FBIO Company Profile >> Back to FBIO Efficiency Comparisons >> Compare FBIO Inventory Turnover Ratio to its Competitors

Financial Statements
Fortress Biotech Inc 's Inventories $ 8 Millions Visit FBIO's Balance sheet
Fortress Biotech Inc 's Cost of Revenues TTM $ 23 Millions Visit FBIO's Income Statement
What are FBIO's Sales? Visit FBIO's Sales by Segment

Other Inventory Turnover Ratios
Fortress Biotech Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
FBIO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for FBIO's Competitors
Inventory Turnover Ratio for FBIO's Suppliers
Inventory Turnover Ratio for FBIO's Customers

You may also want to know
FBIO's Sales Growth Rates FBIO's Pe Price to earnings ratio FBIO's Receivables Turnover Ratio FBIO's Stock Quote
FBIO's Net Income Growth Rates FBIO's Ps Price to Sales ratio FBIO's Sales per Employee FBIO's Asset Turnover Ratio
FBIO's Net Margin FBIO's Pb Price to Book ratio FBIO's Financial Strength Ratios FBIO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions

Date modified: 2026-09-03T11:45:11+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.